HGHSX
Price
$37.25
Change
-$0.41 (-1.09%)
Updated
Apr 16 closing price
Net Assets
856.33M
SHSAX
Price
$60.56
Change
-$0.48 (-0.79%)
Updated
Apr 16 closing price
Net Assets
6.7B
Ad is loading...

HGHSX vs SHSAX

Header iconHGHSX vs SHSAX Comparison
Open Charts HGHSX vs SHSAXBanner chart's image
Hartford Healthcare R4
Price$37.25
Change-$0.41 (-1.09%)
VolumeN/A
Net Assets856.33M
BlackRock Health Sciences Opps Inv A
Price$60.56
Change-$0.48 (-0.79%)
VolumeN/A
Net Assets6.7B
HGHSX vs SHSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGHSX vs. SHSAX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHSX is a Buy and SHSAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.7B vs. HGHSX (856M). SHSAX pays higher dividends than HGHSX: SHSAX (0.21) vs HGHSX (0.00). HGHSX was incepted earlier than SHSAX: HGHSX (18 years) vs SHSAX (25 years). HGHSX (1.29) is less costly to investors than SHSAX (1.09). HGHSX has a lower initial minimum investment than SHSAX: HGHSX (0) vs SHSAX (1000). HGHSX (-8.68) and SHSAX (-8.83) have marching annual gain over last year. SHSAX return over 5 years is better than : -5.25 vs. HGHSX (-6.62).
HGHSXSHSAXHGHSX / SHSAX
Total Expense Ratio1.291.09118%
Annual Report Gross Expense Ratio1.291.09118%
Fund Existence18 years25 years-
Gain YTD-3.535-2.242158%
Front LoadN/A5%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets856M6.7B13%
Annual Yield % from dividends0.000.21-
Returns for 1 year-8.68-8.8398%
Returns for 3 years-10.10-14.5869%
Returns for 5 years-6.62-5.25126%
Returns for 10 years-10.6712.96-82%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIEIX37.51N/A
N/A
Nuveen Equity Index R6
MSEIX65.09N/A
N/A
AMG Veritas Asia Pacific I
JGSVX18.29N/A
N/A
JPMorgan Small Cap Growth R5
BCREX14.12N/A
N/A
BlackRock Real Estate Securities Inv C
HFDCX16.21N/A
N/A
Hartford Schroders US MidCap Opps C